Welcome to Discoverylabs.investorroom.com - Welcome

discoverylabs.investorroom.com

Description: Discoverylabs Investorroom. Windtree Therapeutics is a specialty biotechnology company focused on advancing a new standard in respiratory critical care....

Google PR 0

Trustworthiness Unknown
Avg. Daily Visitors N/A

Child Safety Unknown
Avg. Daily Pageviews N/A

Privacy Unknown

Welcome | Windtree Therapeutics

Discoverylabs.investorroom.com: get to the top rated Discoverylabs Investorroom pages and content popular with India-based Discoverylabs.investorroom.com users or check the following digest to find out more. Discoverylabs.investorroom.com is a malware-free website without age restrictions, so you can safely browse it. It seems that Discoverylabs.investorroom.com team has yet to grow their social media activity, as the major social networks contain little or no materials related to this domain. Discoverylabs.investorroom.com is hosted with CloudFlare, Inc. in United States. Discoverylabs Investorroom traffic is not yet estimated by Alexa.

Visit discoverylabs.investorroom.com

Domain info

Location:	United States
Registrant:	Not Disclosed Not Disclosed (Not Disclosed)
Hosted by:	CloudFlare, Inc.
Registrar:	CSC Corporate Domains, Inc.
Subnetworks:	104.17.202.159, 104.17.203.159, 104.17.204.159, 104.17.205.159, 104.17.206.159

Social Media Activities

Facebook likes: -
Twitter mentions: -
Google pluses: -
LinkedIn mentions: -
Pinterest pins: -
StumbleUpon views: -

Web Safety

This website is malware-free.
Status ok

See Google Transparency Report

Sites associated with the same registrant

Whois

Expand

Discoverylabs.investorroom.com popular pages to visit

Welcome | Windtree Therapeutics Windtree Therapeutics is a global, clinical-stage, biopharmaceutical and medical device company focused on the development of novel therapeutics intended to address significant unmet medical needs in ...

Discovery Labs Announces Enrollment of First Patient in AEROSURF® Phase 2a Dose Expansion Trial - May 20, 2015 Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today reported that the first...

Discovery Labs to Hold Conference Call on Tuesday March 17, 2015 to Discuss Fourth Quarter 2014 Financial Results and Other Discovery Laboratories, Inc. (Nasdaq: DSCO), a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care will host a live teleconference and webcast at...